157 related articles for article (PubMed ID: 640235)
1. 24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics.
Christensen SE; Hansen AP; Weeke J; Lundbaek K
Diabetes; 1978 Mar; 27(3):300-6. PubMed ID: 640235
[TBL] [Abstract][Full Text] [Related]
2. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
3. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
Neuhaus C; Kerner W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics.
Christensen SE; Hansen AP; Orskov H; Lundbaek K
Metabolism; 1978 Sep; 27(9 Suppl 1):1427-31. PubMed ID: 683011
[No Abstract] [Full Text] [Related]
5. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
Villaume C; Beck B; Kolopp M; Toussain P; Debry G
Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
[TBL] [Abstract][Full Text] [Related]
6. Effect of somatostatin on blood sugar, plasma growth hormone, and glucagon levels in diabetic children.
Del Guercio MJ; di Natale B; Gargantini L; Garlaschi C; Chiumello G
Diabetes; 1976 Jul; 25(7):550-3. PubMed ID: 1278605
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin in maturity-onset diabetes.
Christensen SE; Hansen AP; Lundbaek K
Diabetes; 1978 Oct; 27(10):1013-9. PubMed ID: 700257
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
Ward FR; Leblanc H; Yen SS
J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
[TBL] [Abstract][Full Text] [Related]
9. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
[TBL] [Abstract][Full Text] [Related]
10. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF
J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680
[TBL] [Abstract][Full Text] [Related]
11. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ
Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic action of somatostatin after oral glucose loading: due to suppression of glucagon and growth hormone or of intestinal carbohydrate absorption?
Bratusch-Marrain P; Vierhapper H; Grubeck-Loebenstein B; Waldhäusl W; Nowotny P
Horm Metab Res; 1981 Jun; 13(6):305-9. PubMed ID: 6114914
[TBL] [Abstract][Full Text] [Related]
13. The effects of the somatostatin analogue SMS 201-995 on carbohydrate homeostasis of insulin-dependent diabetics as assessed by the artificial endocrine pancreas.
Hadjidakis DJ; Halvatsiotis PG; Ioannou YJ; Mavrokefalos PJ; Raptis SA
Diabetes Res Clin Pract; 1988 Jul; 5(2):91-8. PubMed ID: 2901329
[TBL] [Abstract][Full Text] [Related]
14. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
15. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
[TBL] [Abstract][Full Text] [Related]
16. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
17. Effect of a somatostatin analog on insulin requirement and hormone levels in 6 insulin-dependent juvenile-onset diabetics subjected to artificial pancreas.
Lenti G; Trovati M; Lorenzati R; Vitelli F; Tagliaferro V; Marocco A; Pagano G
Acta Diabetol Lat; 1980; 17(1):9-14. PubMed ID: 6106342
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
Campbell PJ; Bolli GB; Cryer PE; Gerich JE
N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
[TBL] [Abstract][Full Text] [Related]
19. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
[TBL] [Abstract][Full Text] [Related]
20. Effect of somatostatin on metabolic and hormonal changes induced by nicotinic acid in insulin-dependent diabetics.
Luyckx AS; Lefebvre PJ
Diabetologia; 1976 Oct; 12(5):447-53. PubMed ID: 976635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
